Biobanking Market is estimated to increase at a Compounded Annual Growth Rate of 7.9% CAGR over the forecast period from 2024 to 2030
The Biobanking Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Equipment, Consumables, Services, Software), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids, Biological Fluids, Human Waste Products), By Storage (Manual, Automated), By Ownership (Universities, National/Regional Agencies, Non-Profit Organizations, Private Organizations), By Application (Regenerative Medicine, Life Science Research, Clinical Research), By End-User (Pharmaceutical Companies, Biotechnology Companies, CROs, Research Institutes, Hospitals, Others).
An Introduction to Biobanking Market in 2024
Biobanking plays a crucial role in biomedical research and personalized medicine by collecting, storing, and managing biological samples and associated data for future research purposes. In 2024, biobanks encompass a diverse array of repositories, including tissue banks, blood banks, and population-based biobanks, housing samples such as DNA, serum, tissue, and cells from individuals with various health conditions. These valuable resources support translational research, biomarker discovery, and the development of novel therapeutics and diagnostic tools. With advancements in sample storage technologies, data management systems, and ethical standards, biobanking continues to evolve, offering researchers access to well-characterized, high-quality biospecimens and clinical data for advancing biomedical knowledge and improving patient care. As precision medicine initiatives expand and research collaborations grow, biobanking plays an increasingly vital role in accelerating scientific discoveries and translating research findings into clinical practice.
Market Trend: Increasing Demand for Personalized Medicine and Precision Research
One prominent trend in the biobanking market is the increasing demand for personalized medicine and precision research. With advancements in genomics, proteomics, and other omics technologies, there is growing interest in studying the molecular basis of diseases and developing targeted therapies tailored to individual patients' genetic makeup. Biobanks play a crucial role in collecting, storing, and managing biological samples, including tissues, blood, and DNA, along with associated clinical and demographic data, to support research efforts in personalized medicine, pharmacogenomics, and biomarker discovery. This trend reflects the shift towards precision healthcare approaches that prioritize the use of high-quality biospecimens and comprehensive data sets for translational research and therapeutic development, driving the expansion and diversification of biobanking activities worldwide.
Market Driver: Rising Focus on Biomarker Discovery and Drug Development
A significant driver in the biobanking market is the rising focus on biomarker discovery and drug development. Biomarkers are molecular indicators of physiological or pathological processes that can be used for disease diagnosis, prognosis, and treatment response prediction. Biobanks provide researchers and pharmaceutical companies with access to diverse biospecimens and associated data sets needed for biomarker identification, validation, and clinical translation. As the pharmaceutical industry seeks to accelerate drug discovery and development processes, there is a growing demand for high-quality biological samples from well-characterized patient cohorts to support biomarker-driven research and preclinical studies. The emphasis on precision medicine and the development of targeted therapies further drives the demand for biobanking services, positioning biobanks as essential resources in the translational research pipeline and drug development ecosystem.
Market Opportunity: Expansion into Emerging Markets and Disease Areas
An emerging opportunity in the biobanking market is the expansion into emerging markets and disease areas. While biobanking activities have traditionally been concentrated in developed countries and focused on specific disease areas such as cancer and cardiovascular diseases, there is untapped potential to establish biobanks in emerging markets and explore new disease domains. Emerging economies present opportunities for biobanking infrastructure development and capacity building to support research initiatives addressing local healthcare challenges and disease burdens. Additionally, there is potential to expand biobanking efforts beyond traditional disease areas to include rare diseases, infectious diseases, neurodegenerative disorders, and other therapeutic areas with unmet medical needs. By diversifying biobanking portfolios and establishing collaborations with research institutions, healthcare organizations, and biopharmaceutical companies, biobanks can capitalize on emerging opportunities, contribute to scientific advancements, and address global health disparities through data-driven research and innovation.
Biobanking Market Share Analysis: Automated Storage Equipment is the fastest growing segment over the forecast period to 2030
Among the segments in the Biobanking Market, the Automated Storage Equipment segment is experiencing the fastest growth. This growth can be attributed to several factors driving the demand for automated storage solutions in biobanking facilities. Automated storage equipment offers several advantages over manual storage systems, including increased efficiency, higher throughput, and improved sample integrity. Additionally, automated storage systems utilize advanced robotics, barcode technology, and integrated software to streamline sample handling, tracking, and retrieval processes, reducing the risk of errors and contamination. Furthermore, the increasing volume and diversity of samples stored in biobanks, coupled with the growing emphasis on standardized storage conditions and regulatory compliance, drive the adoption of automated storage solutions among biotechnology companies, pharmaceutical companies, research institutes, and hospitals. As biobanking facilities prioritize efficiency, scalability, and sample management capabilities, the Automated Storage Equipment segment is expected to sustain its rapid growth in the Biobanking Market.
Biobanking Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAMS Biotechnology Ltd, ASKION GmbH, Avantor Inc, Azenta Inc, Bay Biosciences LLC, Becton, Dickinson and Company, BioKryo GmbH, Cell&Co BioServices SAS, Cryoport Inc, CTIBiotech, Cureline Inc, Firalis Group, Greiner Holding AG, Hamilton Company, Merck KGaA, Micronic Europe B.V., PHC Holdings Corp, ProteoGenex Inc, QIAGEN N.V., Sopachem NV, SPT Labtech Ltd, Tecan Trading AG, Thermo Fisher Scientific Inc, US Biolab Corp Inc, Ziath Ltd
Biobanking Market Segmentation
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Biobanking Market Companies
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
Reasons to Buy the Biobanking Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Biobanking Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Biobanking Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Biobanking Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Biobanking Market Size Outlook, $ Million, 2021 to 2030
3.2 Biobanking Market Outlook by Type, $ Million, 2021 to 2030
3.3 Biobanking Market Outlook by Product, $ Million, 2021 to 2030
3.4 Biobanking Market Outlook by Application, $ Million, 2021 to 2030
3.5 Biobanking Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Biobanking Industry
4.2 Key Market Trends in Biobanking Industry
4.3 Potential Opportunities in Biobanking Industry
4.4 Key Challenges in Biobanking Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Biobanking Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Biobanking Market Outlook by Segments
7.1 Biobanking Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
8 North America Biobanking Market Analysis and Outlook To 2030
8.1 Introduction to North America Biobanking Markets in 2024
8.2 North America Biobanking Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Biobanking Market size Outlook by Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
9 Europe Biobanking Market Analysis and Outlook To 2030
9.1 Introduction to Europe Biobanking Markets in 2024
9.2 Europe Biobanking Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Biobanking Market Size Outlook by Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
10 Asia Pacific Biobanking Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Biobanking Markets in 2024
10.2 Asia Pacific Biobanking Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Biobanking Market size Outlook by Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
11 South America Biobanking Market Analysis and Outlook To 2030
11.1 Introduction to South America Biobanking Markets in 2024
11.2 South America Biobanking Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Biobanking Market size Outlook by Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
12 Middle East and Africa Biobanking Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Biobanking Markets in 2024
12.2 Middle East and Africa Biobanking Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Biobanking Market size Outlook by Segments, 2021-2030
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AMS Biotechnology Ltd
ASKION GmbH
Avantor Inc
Azenta Inc
Bay Biosciences LLC
Becton, Dickinson and Company
BioKryo GmbH
Cell&Co BioServices SAS
Cryoport Inc
CTIBiotech
Cureline Inc
Firalis Group
Greiner Holding AG
Hamilton Company
Merck KGaA
Micronic Europe B.V.
PHC Holdings Corp
ProteoGenex Inc
QIAGEN N.V.
Sopachem NV
SPT Labtech Ltd
Tecan Trading AG
Thermo Fisher Scientific Inc
US Biolab Corp Inc
Ziath Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Products and Services
Equipment
-Storage Equipment
-Sample Analysis Equipment
-Sample Processing Equipment
-Sample Transport Equipment
Consumables
-Storage Consumables
-Analysis Consumables
-Processing Consumables
-Collection Consumables
Services
-Storage Services
-Processing Services
-Transport Services
-Supply Services
Software
By Sample Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Biological Fluids
Human Waste Products
By Storage
Manual
Automated
By Ownership
Universities
National/Regional Agencies
Non-Profit Organizations
Private Organizations
By Application
Regenerative Medicine
Life Science Research
Clinical Research
By End-User
Pharmaceutical Companies
Biotechnology Companies
CROs
Research Institutes
Hospitals
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
